US Patent Issued to JJP Biologics SP. Z on Sept. 15 for "Humanized anti-human CD89 antibodies and uses thereof" (Dutch Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,490, issued on Sept. 15, was assigned to JJP Biologics SP. Z O.O. (Warsaw, Poland).

"Humanized anti-human CD89 antibodies and uses thereof" was invented by Petrus Johannes Simons (Hillegom, Netherlands), Marcel Theodorus Den Hartog (Monnickendam, Netherlands) and Louis Boon (Badhoevedorp, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure describes a humanized antibody that can bind an extra-cellular part of human CD89 (human FcAlphaRI) on human CD89 expressing cells that prevents binding of human IgA to human CD89 when the antibody is bound to said cells. The disclosure also describes the use of such antibodies in combating ...